Clinical Trials Browser

INDUSTRY × Papillomavirus Infections × halofantrine × Clear all

NCT00541970 2018-08-17

Partially Blind Study to Evaluate Immunogenicity & Safety of GSK Bio's HPV Vaccine 580299 in Healthy Women Aged 9-25 Yrs

Phase 1 Completed

961 enrolled 43 charts

Uterine Cervical Neoplasms, Virus Diseases, Papillomavirus Infections

NCT00426361 2018-07-20

Evaluation of Safety and Immunogenicity of Co-administering Human Papillomavirus (HPV) Vaccine With Other Vaccines in Healthy Female Subjects

Phase 3 Completed

751 enrolled 22 charts

Papillomavirus Infections